These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11881506)

  • 21. [Factors of intestinal microflora persistence in dysbacteriosis].
    Bukharin OV; Valyshev AV
    Vestn Ross Akad Med Nauk; 1997; (3):19-22. PubMed ID: 9181850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pseudomembranous colitis and "intestinal sepsis" as a consequence of dysbacteriosis due to antibiotics].
    Eriukhin IA; Shliapnikov SA; Lebedev VF; Ivanov GA
    Vestn Khir Im I I Grek; 1997; 156(2):108-11. PubMed ID: 9235747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of enterococci on normalizing the intestinal microflora in experimental dysbacteriosis].
    Korshunov VM; Logadyr' TA; Popova SN; Tulina SG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):3-6. PubMed ID: 2588877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The dysbacteriosis of extreme states].
    Liz'ko NN
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):184-6. PubMed ID: 3579245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of efficacy of the use of coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants].
    Litvinova AM; Chtetsova VM; Kavtreva IG
    Vopr Okhr Materin Det; 1978 Sep; 23(9):42-4. PubMed ID: 716289
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dysbacteriosis: modern conceptions. Diagnosis. Possible management].
    Mitrokhin SD
    Antibiot Khimioter; 2004; 49(7):22-33. PubMed ID: 15690911
    [No Abstract]   [Full Text] [Related]  

  • 27. [Participation of conditionally pathogenic enterobacteria in the processes of intestinal dysbacteriosis].
    Kalashnikova GK; Zhukovskaia NA; Balanin NV
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):57-62. PubMed ID: 665052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of intestinal dysbacteriosis in the pathology of young children].
    Serebriakova NN; Kaz'mina GK
    Vopr Okhr Materin Det; 1972 May; 17(5):17-9. PubMed ID: 5029745
    [No Abstract]   [Full Text] [Related]  

  • 29. [Probiotics: from Metchnikoff to the current preventive and therapeutic possibilities].
    Caramia G
    Pediatr Med Chir; 2004; 26(1):19-33. PubMed ID: 15529809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.
    Plaza-Díaz J; Ruiz-Ojeda FJ; Gil-Campos M; Gil A
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microecological aspects of small intestinal bacterial overgrowth syndrome].
    Bondarenko VM; Lykova EA; Matsulevich TV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):57-63. PubMed ID: 17163142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics as modulators of the gut flora.
    Fooks LJ; Gibson GR
    Br J Nutr; 2002 Sep; 88 Suppl 1():S39-49. PubMed ID: 12215180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Distribution of intestinal dysbacteriosis among children].
    Krivogorskiĭ EB; Meshcherekova KM; Malkina RD; Mikitina RV
    Vopr Okhr Materin Det; 1974 May; 19(5):89. PubMed ID: 4464651
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intestinal dysbacteriosis in antibacterial therapy and perspectives in treatment by antibiotic-resistant probiotics].
    Lykova EA
    Antibiot Khimioter; 2001; 46(3):21-5. PubMed ID: 11548277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Large intestine dysbacteriosis and therapy efficacy in patients with respiratory tract tuberculosis in sanatoria].
    Dugina NN; Chebotareva TV; Mitrokhin SD
    Antibiot Khimioter; 2004; 49(4):35-8. PubMed ID: 15460021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience with the treatment of severe forms of intestinal toxicosis in young children].
    Mikhalev VN; Blaibis VA
    Tr Inst Im Pastera; 1985; 63():152-7. PubMed ID: 3843153
    [No Abstract]   [Full Text] [Related]  

  • 38. [The significance of individual carboxylic acids in the feces in the diagnosis of dysbacteriosis].
    Mitrokhin SD; Ivanov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):99-101. PubMed ID: 9381887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasmapheresis in the therapy of infection, destructive pneumonia and intestinal toxicosis in children].
    Manerov FK; Romanov MG; Chernov OM; Dvukhzhil'nov SI; Solopon VP
    Pediatriia; 1988; (9):56-61. PubMed ID: 3200640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.